At Rusan Healthcare, we believe recovery from addiction isn't just about quitting—it's about reclaiming your life. Whether it's tobacco, alcohol, or drugs, our de-addiction therapies are scientifically designed to reduce cravings, ease withdrawal symptoms, and support long-term recovery.
Reduce the risk of relapse
Science-backed care for addiction free life
Trusted solutions for freedom from addiction
Empowering journeys from dependence to renewal
Rusan offers WHO-approved treatments for Opioid Substitution Therapy (OST) to support recovery from opioid dependence. We provide a complete range of formulations, including Methadone, Buprenorphine, fixed-dose combinations of Buprenorphine and Naloxone, and antagonist therapies like Naltrexone and Naloxone. These solutions help by reducing the effects of opioids, relieving withdrawal symptoms, and supporting patients on their journey to a drug-free and productive life.
Reduces Opioid Effects
Supports Long-Term Recovery
Reduces Withdrawal Symptoms
Alcohol addiction is a medical condition—but with the right treatment, recovery is achievable. At Rusan, we offer scientifically backed medications to support individuals on their recovery journey. One such product is the Naltrexone tablet—a first-line treatment with strong clinical evidence for its effectiveness in reducing alcohol cravings and preventing relapse.
Relapse Prevention
Safe for Recovery Stages
Supports Mental & Physical Health
Tobacco addiction affects both the body and the mind—but it can be overcome with the right support. Rusan offers Nicotine Replacement Therapies (NRTs) that help reduce cravings and withdrawal symptoms, making it easier to quit smoking or chewing tobacco. Our trusted products, available as transdermal Nicotine Patches and Nicotine Gums, are designed to deliver a gradual, steady dose of nicotine, helping users quit safely and more comfortably.
Support for Every Stage
Clinically Proven Solutions
Gradual Nicotine Reduction
At Rusan, we combine compassion, innovation, and science to help people regain control over their lives.
Backed by WHO, USFDA, and Health Canada approvals.
Targeted therapies for tobacco, alcohol, and drug dependence.
Used in government programs, hospitals, and clinics across 35+ countries.
Backed by WHO, USFDA, and Health Canada approvals.
Targeted therapies for tobacco, alcohol, and drug dependence.
Used in government programs, hospitals, and clinics across 35+ countries.
Backed by WHO, USFDA, and Health Canada approvals.
Targeted therapies for tobacco, alcohol, and drug dependence.
Used in government programs, hospitals, and clinics across 35+ countries.